Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

FDA Approves Pill With Sensor To Send Information To Doctor

This photo provided by Otsuka America Pharmaceutical, Inc. shows a rendering of the packaging for Abilify MyCite. On Monday, Nov. 13, 2017, the FDA approved Abilify MyCite, the first drug in the United States with a digital ingestion tracking system, in an unprecedented move to ensure that patients with mental illness take the medicine prescribed for them. (Otsuka America Pharmaceutical, Inc. via AP)
This photo provided by Otsuka America Pharmaceutical, Inc. shows a rendering of the packaging for Abilify MyCite. On Monday, Nov. 13, 2017, the FDA approved Abilify MyCite, the first drug in the United States with a digital ingestion tracking system, in an unprecedented move to ensure that patients with mental illness take the medicine prescribed for them. (Otsuka America Pharmaceutical, Inc. via AP)

A new antipsychotic pill contains an ingestible sensor which can transmit information to the patient’s doctor. The pill is designed to help patients take medication consistently, but it also raises some privacy concerns.

Rebecca Robbins (@rebeccadrobbins) of our partner STAT discusses with Here & Now‘s Jeremy Hobson.

Copyright 2021 NPR. To see more, visit https://www.npr.org.